MoonLake Immunotherapeutics
MLTX
#3633
Rank
NZ$5.19 B
Marketcap
$82.35
Share price
-2.40%
Change (1 day)
-9.64%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -NZ$0.18 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$96.91 Million, an increase over its 2022 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.18 Billion80.66%
2023 -NZ$96.91 Million-16.81%
2022 -NZ$0.12 Billion